Di-tert-butyl 3,3'-azanediyldipropanoate, 97.0%, 250mg

N,N-Bis(2,5-dihydroxybenzylidene)ethylenediamine, 98.0%, 250mg

3-(5,6-Dimethyl-1H-benzimidazol-1-yl)propanoic acid hydrochloride, 95.0%, 500mg

2-(Tert-butoxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 250mg

5-Hydroxypiperidine-2-carboxylic acid, 95%, 250mg

(1S,3S,6R)-7,7-Difluorobicyclo[4.1.0]heptan-3-amine hydrochloride, 250mg

Acétone, min 99,5 %, pour la synthèse, 5 l, emballage plastique.

7-methyl-[1,2,4]triazolo[1,5-a]pyridin-2-amine, 95+%, 250mg

Fullerene C60 (pure)>99.5%(HPLC)1g

2-(4-Chlorophenyl)piperazine, 95.0%, 250mg

2-Amino-3-((tert-butyldiphenylsilyl)oxy)-2-methylpropan-1-ol, 95%, 5g

4,5-Dichlorophthalonitrile, 95.0%, 25g

1-Morpholin-2-ylmethanamine, 97.0%, 250mg